Search
AstraZeneca and CSPC Pharmaceutical Group Form Strategic Partnership for AI-Powered Drug Research
2 day ago /
Read about 0 minute
Author：小编
AstraZeneca and CSPC Pharmaceutical Group have announced a strategic research collaboration aimed at advancing the discovery and development of novel oral drug candidates for the treatment of multiple diseases. This partnership will focus on high-priority targets, leveraging CSPC's efficient drug discovery platform, which is fueled by a dual-wheel AI engine. As part of the agreement, CSPC will receive an upfront payment of USD 110 million, along with milestone payments and sales royalties that could potentially reach up to USD 5.22 billion. AstraZeneca will hold the exclusive global rights to develop and commercialize the resulting drug candidates.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
